These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5688369)

  • 1. Determining the professional fee.
    Smith HA
    J Am Pharm Assoc; 1968 Dec; 8(12):646-9. PubMed ID: 5688369
    [No Abstract]   [Full Text] [Related]  

  • 2. Professional fee: renaissance or innovation?
    Myers MJ
    J Am Pharm Assoc; 1968 Dec; 8(12):628-31. PubMed ID: 5688365
    [No Abstract]   [Full Text] [Related]  

  • 3. Professional fee in pharmaceutical practice.
    Myers MJ
    J Am Pharm Assoc; 1968 Dec; 8(12):632-5. PubMed ID: 5688366
    [No Abstract]   [Full Text] [Related]  

  • 4. Advantages of the professional fee.
    Myers MJ
    J Am Pharm Assoc; 1968 Dec; 8(12):639-43. PubMed ID: 5688368
    [No Abstract]   [Full Text] [Related]  

  • 5. Professional fee experiences.
    Myers MJ
    J Am Pharm Assoc; 1968 Dec; 8(12):636-8 passim. PubMed ID: 5688367
    [No Abstract]   [Full Text] [Related]  

  • 6. The professional fee--why and how?
    Myers MJ
    Am J Pharm Sci Support Public Health; 1968; 140(4):101-19. PubMed ID: 5678242
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost of dispensing in the pharmaceutical services.
    Opit LJ; Farmer RD
    Lancet; 1974 Feb; 1(7849):160-2. PubMed ID: 4129726
    [No Abstract]   [Full Text] [Related]  

  • 8. Health care cost control by third party payors: fee schedules and the Sherman Act.
    Kallstrom DW
    Duke Law J; 1978 May; (2):645-97. PubMed ID: 10239068
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship of price, practice setting and quality of pharmaceutical services.
    Rowles B; Wertheimer AI
    Drug Intell Clin Pharm; 1976 Apr; 10(4):219-21. PubMed ID: 10236236
    [No Abstract]   [Full Text] [Related]  

  • 10. Public policy considerations in the pricing of prescription drugs in the United States.
    Rucker TD
    Int J Health Serv; 1974; 4(1):171-9. PubMed ID: 4829895
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible impact of government drug program on community pharmacies.
    Rucker TD
    J Am Pharm Assoc; 1971 Jun; 11(6):334-7. PubMed ID: 4940804
    [No Abstract]   [Full Text] [Related]  

  • 12. Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012.
    Ha D; Song I; Lee EK; Shin JY
    BMC Health Serv Res; 2018 May; 18(1):327. PubMed ID: 29724220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of prescription prices and professional services.
    Campbell RK; Grisafe JA
    J Am Pharm Assoc; 1977 Mar; 17(3):164-7. PubMed ID: 845376
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacy financial management.
    Berger BA; Pearson RE
    J Pharm Mark Manage; 1986; 1(2):73-90. PubMed ID: 10282752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present and projected drug system services in a highly developed HMO structure.
    Johnson RE
    Health Serv Rep; 1973 Nov; 88(9):873-7. PubMed ID: 4759561
    [No Abstract]   [Full Text] [Related]  

  • 16. Considerations in establishing fees for home-care pharmaceutical services.
    Mirtallo JM
    Am J Hosp Pharm; 1989 Jul; 46(7 Pt 2):S15-7. PubMed ID: 2672803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug prescribing and use in an American community.
    Stolley PD; Becker MH; McEvilla JD; Lasagna L; Gainor M; Sloane LM
    Ann Intern Med; 1972 Apr; 76(4):537-40. PubMed ID: 4640311
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial: generic prescriptions: can the consumer benefit?
    Gumbhir AK; Rodowskas CA
    Ann Intern Med; 1975 May; 82(5):711-12. PubMed ID: 1137267
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial: Hospital charges for pharmaceutical services.
    Zellmer WA
    Am J Hosp Pharm; 1974 Nov; 31(11):1043. PubMed ID: 4432851
    [No Abstract]   [Full Text] [Related]  

  • 20. Economic problems in drug distribution.
    Rucker TD
    Inquiry; 1972 Sep; 9(3):43-50. PubMed ID: 4262974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.